By Alan Doherty In our field, we see something of a regular conveyor belt of new treatments promising “revolutionary” results for patients. I see my professional stance towards new developments as being that of the informed cynic – I am always keen to learn and utilise technology that improves outcomes for patients. But I have […]
Read more
By Maya Harris, consultant urologist, Birmingham Prostate Clinic I first came across this new procedure in America four years ago, whilst attending a meeting of the American Urological Association. I was surprised by the simplicity and elegance of the idea that rather than removing the prostate tissue, it could be retracted to open the passage […]
Read more Earlier this year, a new approach to benign prostatic hyperplasia (BPH) received approval for use in the NHS. The new approach is called UroLift and is designed to alleviate the symptoms of BPH without cutting or vaporising the surplus prostate tissue. To understand this new treatment, we need to start by looking at what happens […]
Read more
What is my risk of prostate cancer? Prostate cancer is the most common male cancer, affecting one in every nine men. Your personal risk doubles if you have a first degree relative (father or brother) with the disease, particularly if they develop prostate cancer before the age of 60. Prostate cancer risk is also increased […]
Read more
For about 20 to 30 per cent of men diagnosed with prostate cancer, by the time they are seen by a doctor, their disease has spread to other parts of the body. This means their prostate cancer cannot be cured and is known as metastatic disease. The first course of action is to control the […]
Read more